How to Help Your Patients Save Money on Lotemax: A Provider's Guide to Savings Programs

Medication cost is one of the leading causes of non-adherence to post-surgical eye drop regimens — and the consequences of stopping or skipping steroid drops after cataract surgery are severe. Cystoid macular edema, increased infection risk, prolonged inflammation, and compromised visual outcomes can all result from cost-driven non-adherence. As the prescriber, you have more influence over this problem than you may realize.

This guide gives you a comprehensive overview of every cost-reduction pathway available for Lotemax in 2026, organized for efficient use by your clinical team.

Understanding the Lotemax Cost Landscape

The retail cash price for Lotemax formulations is substantial:

Lotemax suspension 0.5%: ~$155 retail for 5 mL

Lotemax gel 0.5%: ~$315 retail for 5 g

Lotemax ointment 0.5%: ~$441 retail for 3.5 g

Lotemax SM gel 0.38%: ~$316 retail for 5 g

Most commercial insurance plans and Medicare Part D either exclude brand-name Lotemax or place it on Tier 3–4, resulting in high patient copays. Without intervention from your practice, many patients will either fill the prescription at full cash price, delay filling while seeking lower cost options, or — most dangerously — skip doses.

Pathway 1: Bausch + Lomb Manufacturer Savings Programs

Bausch + Lomb maintains two complementary programs for Lotemax:

The Bausch + Lomb Access Program (bauschcopayprogram.com)

Eligible commercially insured patients: As low as $25/fill at Walgreens or participating pharmacies; $35/fill at other pharmacies

Uninsured patients: As low as $69/fill at Walgreens; $79/fill elsewhere

How to enroll: Online at bauschcopayprogram.com, by phone at 1-866-693-4880, or by texting BLSAVINGS to 24109

Exclusions to know: Federal employees, Medicaid, and TRICARE patients are typically not eligible. Confirm eligibility criteria on the program website.

The Bausch + Lomb Part D Opt-Out Cash Purchase Program (blpartdcoupon.com)

Eligible Medicare Part D patients: As low as $79/fill by opting out of using their Part D benefit for this fill

Important: Patients must opt out of using their Part D benefit for this specific fill — purchases using this card cannot count toward their Part D true out-of-pocket cost. Advise patients who are close to their Part D OOPM to discuss with their plan before using this option.

Pathway 2: GoodRx and Third-Party Discount Programs

For patients who may not qualify for manufacturer programs or who prefer a simpler solution, GoodRx provides significant savings:

Lotemax suspension: As low as ~$49 (68% off retail)

Lotemax gel, ointment, and SM: As low as ~$80 (75–82% off retail)

Advise patients to compare GoodRx with the manufacturer program — manufacturer cards often beat GoodRx, but results vary by pharmacy and drug. GoodRx and manufacturer coupons cannot be combined.

Pathway 3: Prescribing Generic When Clinically Appropriate

Generic loteprednol etabonate ophthalmic suspension 0.5% is available and significantly less expensive. For patients who require the suspension formulation (not gel, ointment, or SM), prescribing "loteprednol etabonate ophthalmic suspension 0.5% — generic acceptable" allows the pharmacist to dispense the generic when available, reducing cost to ~$50–$80 even without a coupon.

Note: Some providers prefer brand Lotemax suspension due to formulation differences in inactive ingredients and particle characteristics. If you have a clinical preference for the branded product, write "Brand Medically Necessary" on the prescription and document the rationale.

Pathway 4: Prior Authorization — When and How to Fight for Coverage

When a patient's insurance could cover Lotemax but requires prior authorization, successful PA documentation should include:

The specific indication: post-cataract surgery inflammation (ICD-10: H59.011–H59.013 or H59.09) is the most favorably reviewed

Patient-specific medical necessity: glaucoma diagnosis, prior IOP elevation, history of steroid response making prednisolone inappropriate

For step therapy appeals: note that requiring a patient to fail on prednisolone post-cataract surgery is clinically inappropriate and could cause measurable harm — many state laws now restrict step therapy for post-surgical cases

Practice Workflow: Building a Cost-of-Care Protocol for Lotemax

We recommend building a simple workflow into your pre-op process:

Insurance verification: Run benefit check for Lotemax at same time as surgical authorization

PA submission: File if required, including medical necessity documentation

Savings card handout: Print or email the Bausch + Lomb program info to all patients at the pre-op visit

Generic authorization: For suspension formulations where brand is not medically necessary, allow generic substitution in the prescription

Backup plan on file: Have an alternative prescription ready to send same-day for patients who still can't fill Lotemax

For practices looking to reduce after-hours calls related to medication access, medfinder for providers is a service that helps patients find their prescriptions at nearby pharmacies — reducing the burden on your front desk and on-call staff.